PROBIOTICS DESIGNED TO IMPROVE SKIN PROBLEMS SUCH AS ACNE, ROSACEA, DERMATITIS, ETC.
FLORA PIEL is a food supplement formulated with probiotics, olive, and vitamins which from the first month of use will help maintain skin in good condition thanks to its biotin content. Moreover, it helps with normal functioning of the immune system due to its Vitamin A content.
This product is aimed at people who suffer from skin complaints caused by conditions such as dermatitis, psoriasis, rosacea acne or other conditions caused by stress, poor diet, etc.
Probiotics are made up of bifidobacteria and lactobacillus which help restore intestinal flora to a healthy condition and strengthen the immune system, which in turn helps reduce skin complaints.
One capsule of FLORA PIEL contains 1x109 colony forming units of a mixture of Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus rhamnosus and Bifidobacterium animalis subsp. lactis.
The probiotics contained in this product are safe and beneficial for our health. They are on the approved list of the EFSA (European Food Safety - QPS: Qualified Presumption of Safety).
FLORA PIEL does not contain gluten or lactose and is suitable for vegetarians.
The probiotics in FLORA PIEL have been selected based on the results of preclinical and clinical trials. They are proven to be capable of reducing the symptoms of a range of skin complaints, such as dermatitis, atopic eczema, psoriasis, acne or rosacea, as well as strengthening the effects of other treatments used to combat these conditions.
FLORA PIEL is resistant to antibiotics and survives contact with stomach acids.
GLUTEN FREE, LACTOSE FREE AND SUITABLE FOR VEGANS.
Recommended Daily Dose: 1 capsule (taken orally).
Quantity provided by recommended daily dose:
300 mg of olive leaf and fruit extract (Olea europaea L.) which provides 30 mg Oleuropein and 15 mg of Hidroxitirosol, 1*109 CFU of the mixture of Lactobacillus acidophilus, Lactobacillus casei, Lactobacillus rhamnosus and Bifidobacterium animalis subsp. lactis, 14 mg of Beta-carotene (30% of *RDI of Vitamin A), D-Biotin (100% of *RDI of Biotin) and Riboflavin (30% of *RDI of Vitamin B2). *RDI: Recommended Daily Intake.
Other ingredients: Loading agent (Maltodextrin), Capsule coating (Hypromelose), Anti-caking agent (Magnesium Stearate).
Directions for use: Take 1 capsule per day for 3 months. Repeat the course if necessary.
For children under the age of 3, open the capsule and pour the contents directly into the mouth or dissolve in cool water, juice, or milk.
Format: 30 VEGETABLE CAPSULES.
Container: Its capsule bottle has an ideal seal and packaging that guarantee long-term stability of microorganisms.
Price: € 18.90 (VAT included)
Warnings and recommendations: Do not exceed recommended daily dose. Food supplements are not a substitute for a varied balanced diet and a healthy lifestyle. Store out of reach and out of sight of small children. Consult your G.P. in the case of pregnancy or breast-feeding.
- Bertelsen, R. J., Brantsaeter, A. L., Magnus, M. C., Haugen, M., Myhre, R., Jacobsson, B., Longnecker, M. P., Meltzer, H. M. and London, S. J. (2014). Probiotic milk consumption in pregnancy and infancy and subsequent childhood allergic diseases. J Allergy Clin Immunol 133, 165-71 e1-8.
- Bowe, W. P. (2013). Probiotics in acne and rosacea. Cutis 92, 6-7.
- Fabbrocini, G., Bertona, M., Picazo, O., Pareja-Galeano, H., Monfrecola, G. and Emanuele, E. (2016). Supplementation with Lactobacillus rhamnosus SP1 normalises skin expression of genes implicated in insulin signalling and improves adult acne. Benef Microbes 7, 625-630.
- Farid, R., Ahanchian, H., Jabbari, F. and Moghiman, T. (2011). Effect of a new synbiotic mixture on atopic dermatitis in children: a randomized-controlled trial. Iran J Pediatr 21, 225-30.
- Gerasimov, S. V., Vasjuta, V. V., Myhovych, O. O. and Bondarchuk, L. I. (2010). Probiotic supplement reduces atopic dermatitis in preschool children: a randomized, double-blind, placebo-controlled, clinical trial. Am J Clin Dermatol 11, 351-61.
- Gruber, C., Wendt, M., Sulser, C., Lau, S., Kulig, M., Wahn, U., Werfel, T. and Niggemann, B. (2007). Randomized, placebo-controlled trial of Lactobacillus rhamnosus GG as treatment of atopic dermatitis in infancy. Allergy 62, 1270-6.
- Jung, G. W., Tse, J. E., Guiha, I. and Rao, J. (2013). Prospective, randomized, open-label trial comparing the safety, efficacy, and tolerability of an acne treatment regimen with and without a probiotic supplement and minocycline in subjects with mild to moderate acne. J Cutan Med Surg 17, 114-22.
- Kalliomaki, M., Salminen, S., Poussa, T. and Isolauri, E. (2007). Probiotics during the first 7 years of life: a cumulative risk reduction of eczema in a randomized, placebo-controlled trial. J Allergy Clin Immunol 119, 1019-21.
- Kim, J. Y., Kwon, J. H., Ahn, S. H., Lee, S. I., Han, Y. S., Choi, Y. O., Lee, S. Y., Ahn, K. M. and Ji, G. E. (2010). Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol 21, e386-93.
- Krutmann, J. (2009). Pre- and probiotics for human skin. J Dermatol Sci 54, 1-5.
- Matsumoto, M., Ebata, T., Hirooka, J., Hosoya, R., Inoue, N., Itami, S., Tsuji, K., Yaginuma, T., Muramatsu, K., Nakamura, A. et al. (2014). Antipruritic effects of the probiotic strain LKM512 in adults with atopic dermatitis. Ann Allergy Asthma Immunol 113, 209-216 e7.
- Navarro-Lopez, V., Martinez-Andres, A., Ramirez-Bosca, A., Ruzafa-Costas, B., Nunez-Delegido, E., Carrion-Gutierrez, M. A., Prieto-Merino, D., Codoner-Cortes, F., Ramon-Vidal, D., Genoves-Martinez, S. et al. (2019). Efficacy and Safety of Oral Administration of a Mixture of Probiotic Strains in Patients with Psoriasis: A Randomized Controlled Clinical Trial. Acta Derm Venereol 99, 1078-1084.
- Roessler, A., Friedrich, U., Vogelsang, H., Bauer, A., Kaatz, M., Hipler, U. C., Schmidt, I. and Jahreis, G. (2008). The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention. Clin Exp Allergy 38, 93-102.
- Wickens, K., Black, P., Stanley, T. V., Mitchell, E., Barthow, C., Fitzharris, P., Purdie, G. and Crane, J. (2012). A protective effect of Lactobacillus rhamnosus HN001 against eczema in the first 2 years of life persists to age 4 years. Clin Exp Allergy 42, 1071-9.